【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting
NQ Score
49/100
N1 Content Completeness
10
AI Summary (NQ-processed)
ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.
AI Analysis
Frequently Asked Questions
- Q: When will the dividends be paid?
- A: The specific payment date will be announced separately by the company.
- Q: What does lifting non-compete restrictions mean?
- A: It allows directors to hold positions in other companies, facilitating broader industry collaboration.